Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Immunotherapy|January 23, 2025
Survival impact of immune-related adverse events in extensive stage small cell lung cancer patients: a retrospective cohort studyJohn C Hunting, Sarah N Price, Andrew T Faucheux, et al.
Heart Rhythm|April 27, 2005
Feasibility and validation of registration of three-dimensional left atrial models derived from computed tomography with a noncontact cardiac mapping systemJasbir Sra, David Krum, John Hare, et al.
JCI Insight|July 24, 2019
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolutionAbdel Nasser Hosein, Huocong Huang, Zhaoning Wang, et al.
Advances in Experimental Medicine and Biology|September 25, 2010
Standardizing the next generation of bioinformatics software development with BioHDF (HDF5)Christopher E Mason, Paul Zumbo, Stephan Sanders, et al.
Molecular Cancer Therapeutics|January 3, 2023
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene MaraleucelN Eric Olson, Seamus P Ragan, David J Reiss, et al.
Vascular Medicine (London, England)|November 8, 2014
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery diseaseEric Olson, Laura Demopoulos, Thomas F Haws, et al.
Immunotherapy|January 10, 2024
Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitorsJohn C Hunting, Andrew T Faucheux, Sarah N Price, et al.
Scientific Reports|April 21, 2017
Regulation of intraocular pressure by microRNA cluster miR-143/145Xinyu Li, Fangkun Zhao, Mei Xin, et al.
Multiple Sclerosis and Related Disorders|October 12, 2022
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapySam A Bazzi, Cole Maguire, Nisha Holay, et al.
JACC. Heart Failure|April 4, 2016
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection FractionJohn J Lepore, Eric Olson, Laura Demopoulos, et al.
Pageof 7